Literature DB >> 8790235

The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study.

B C Jost1, G T Grossberg.   

Abstract

OBJECTIVE: To characterize the natural history of Alzheimer's Disease (AD); in particular, to determine the prevalence and time of onset of psychiatric symptoms.
DESIGN: Retrospective medical records review.
SETTING: Regional brain bank operated by a university hospital. PARTICIPANTS: One hundred randomly selected autopsy-confirmed AD patients. MEASUREMENTS: The presence of psychiatric symptoms (e.g., anxiety, wandering, agitation) was documented, and the time of onset relative to diagnosis was measured.
RESULTS: Irritability, agitation, and aggression were documented in 81 patients (81%) an average of 10 months after diagnosis. A total of 72% of patients experienced depression, changes in mood, social withdrawal, and suicidal ideation more than 2 years before diagnosis (26.4 months). Hallucinations, paranoia, accusatory behavior, and delusions were documented around the time of diagnosis (0.1 months after diagnosis) in 45% of patients. Patients with early-onset disease, more years of formal education, and male gender experienced psychiatric symptoms later, relative to diagnosis, than their counterparts.
CONCLUSIONS: Psychiatric manifestations of depression may herald a diagnosis of AD, as such behaviors occurred more than 2 years before diagnosis, on average, in this cohort. Psychotic symptoms manifested around the time of diagnosis, perhaps even prompting diagnosis, whereas agitative symptoms occurred in the first year after diagnosis. The evolution of psychiatric symptoms in this cohort differed according to age at onset of disease, years of formal education, and gender.

Entities:  

Mesh:

Year:  1996        PMID: 8790235     DOI: 10.1111/j.1532-5415.1996.tb02942.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  57 in total

Review 1.  Neuropsychiatric aspects of Alzheimer's disease.

Authors:  C Ballard; M Walker
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

Review 2.  Neuropsychiatry of aggression.

Authors:  Scott D Lane; Kimberly L Kjome; F Gerard Moeller
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

3.  Behavioral disturbance in dementia.

Authors:  Abhilash K Desai; Lori Schwartz; George T Grossberg
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

4.  Methodological issues in the non pharmacological treatment of BPSD in nursing home--the TNM study.

Authors:  E Leone; A Deudon; N Maubourguet; X Gervais; P H Robert
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

Review 5.  Detection of depression in older adults with dementia.

Authors:  Ellen L Brown; Patrick Raue; Karen D Halpert; Susan Adams; Marita G Titler
Journal:  J Gerontol Nurs       Date:  2009-02       Impact factor: 1.254

6.  Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease.

Authors:  Monica Marchese; David Cowan; Elizabeth Head; Donglai Ma; Khalil Karimi; Vanessa Ashthorpe; Minesh Kapadia; Hui Zhao; Paulina Davis; Boris Sakic
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 7.  New atypical antipsychotics. Experience and utility in the elderly.

Authors:  R A Sweet; B G Pollock
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

8.  "Dementia-friendly hospitals: care not crisis": an educational program designed to improve the care of the hospitalized patient with dementia.

Authors:  James E Galvin; Barbara Kuntemeier; Noor Al-Hammadi; Jessica Germino; Maggie Murphy-White; Janis McGillick
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Oct-Dec       Impact factor: 2.703

9.  3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.

Authors:  Elaine K Hebda-Bauer; Tracy A Simmons; Andrew Sugg; Eren Ural; James A Stewart; James L Beals; Qiang Wei; Stanley J Watson; Huda Akil
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  [Antipsychotics for treatment of neuropsychiatric disorders in dementia].

Authors:  H-J Gertz; G Stoppe; B Müller-Oerlinghausen; L G Schmidt; C Baethge; C Hiemke; K Lieb; T Bschor
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.